InnoPharma Inc. Announces Commercial Launch of Acamprosate Delayed-Release Tablets in the United States
15 août 2013 08h00 HE
|
InnoPharma, Inc
PISCATAWAY, NJ, Aug. 15, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc.
today announced the launch of acamprosate calcium, 333 mg
delayed-release tablets (generic equivalent of
Campral®). ...